Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
775 Views
eMediNexus 26 June 2018
The goal of a new study published in Helicobacter aimed to validate the eradication rate of vonoprazan-based first-line triple therapy – combined with clarithromycin and amoxicillin, (V-AC) using clarithromycin (CAM)-susceptible testing. In this multicenter, prospective, randomized trial, 147 treatment-naïve H. pylori-positive patients were enrolled, of which 41 were with CAM-resistant infections and 106 had CAM-susceptible infections. The CAM-susceptible group patients were randomized to either the V-AC group (vonoprazan 20 mg bid, amoxicillin 750 mg bid, and clarithromycin 200 or 400 mg bid) or PPI-AC group (esomeprazole 20 mg bid; amoxicillin 750 mg bid; and clarithromycin 200 or 400 mg bid). The findings showed that all CAM-resistant H. pylori were eradicated by V-AC. On the other hand, the eradication rate of PPI-AC treatment in the CAM-susceptible H. pylori-infected patients was higher. Thus, it was inferred that PPI-AC is more efficacious for the treatment of CAM-susceptible H. pylori infection.
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}..
High 1-hour Plasma Glucose: Early Indicator of Type 2 Diabetes Risk..
Maintaining Liver Health to Optimize Glycemic Outcomes in Early Type 2.....
Antibiotic Prescribing Practices for Pediatric Acute Otitis Media..
Hidden Hazard of Indoor Pollution in COPD..
Recognizing Pitfalls of Point-of-Care Lung Ultrasound..
{{Article_Title}}..
HMPV in India: Seven Cases Reported across Four States..
West Bengal Commission Fines Divine Nursing Home Rs 10 Lakh for Medical Negligence..
India Reports First Human Metapneumovirus (HMPV) Cases in Karnataka..
Two-Year-Old Dies after Wrong Injection Administered by Private Compounder in Jaisalmer..
'Law of the Land' Paramount for Blinkit's Ambulance Services, Says PiyushGoyal..